Wanhua Chemical Group Co Ltd (600309)
Shanghai Stock Exchange · China · prices in CNY · close of 23 Oct 2026
Key indicators
| Last close | CNY 66.90 |
|---|---|
| 52-week range | 60.69 – 97.00 |
| Return, 1 month / 3 months | −6.6% / −11.4% |
| Return, 1 year / 3 years | +6.6% / −20.2% |
| Trend | Below its 200-day average |
| RSI (14) | 41 |
| Volatility (1 year) | 35.6% |
| Worst drawdown (1 year) | -31.1% |
| Average daily value traded | 2,203.89M CNY |
| Dividend yield | – |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Wanhua Chemical Group is a chemicals company based in Yantai, China. It makes polyurethane materials, including isocyanate products used in foams, coatings, adhesives and elastomers, alongside petrochemical and specialty chemical products. Its customers come from industries such as construction, automotive, appliances, furniture and footwear, and it supplies manufacturers in China and other markets. The company also operates production facilities outside China and provides related technical and application support to its industrial customers.
Wanhua Chemical Group Co Ltd trades under the code 600309 on the Shanghai Stock Exchange in China, with its price quoted in Chinese yuan (CNY). Our dividend records, which start in 2019, show payments in 5 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Wanhua Chemical Group Co Ltd (600309) trades on the Shanghai Stock Exchange in China. It last closed at CNY 66.90 on 23 October 2026.
Its price-based Market X-Ray is 65 out of 100 (a fair price profile), ranking 451 of 2,278 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price rose 6.6% and over the last three months it fell 11.4%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on Shanghai Stock Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 57 · Fair | Mixed trend against its averages. | |
| Above 200-day average | -14.1% | ||
| From 52-week high | -29.1% | ||
| Momentum | 43 · Weak | Lagging most stocks on this exchange. | |
| 3-month return | -11.4% | ||
| 6-month return | -23.7% | ||
| 12-month return, skipping the last month | 14.1% | ||
| Stability (higher is calmer) | 77 · Strong | Calmer than most: low volatility and shallow drawdowns. | |
| Volatility, 1 year (lower is calmer) | 35.6% | ||
| Worst drawdown, 1 year (smaller is calmer) | -31.1% | ||
| Liquidity | 97 · Strong | Trades actively. | |
| Average daily value traded | 2,203.89M CNY | ||
| Zero-volume days | 0.0% | ||
| Income | – | Pays no dividend. | |
| Dividend yield | – | ||
| Years with dividends | 2 |
Strengths
- Stability (higher is calmer): Calmer than most: low volatility and shallow drawdowns.
- Liquidity: Trades actively.
Weak spots
- Momentum: Lagging most stocks on this exchange.
Returns
| 1 week | +1.0% |
|---|---|
| 1 month | −6.6% |
| 3 months | −11.4% |
| 6 months | −23.7% |
| 1 year | +6.6% |
| 3 years | −20.2% |
| 5 years | −36.6% |
Signals
| 50-day / 200-day average | 72.26 / 77.89 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 1.86 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 26 May 2023 | CNY 1.6000 |
| 29 Apr 2022 | CNY 2.5000 |
| 26 Apr 2021 | CNY 1.3000 |
| 15 May 2020 | CNY 1.3000 |
| 27 May 2019 | CNY 2.0000 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on Shanghai Stock Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.